|

Effectiveness of Introducing Ultra-High B-Value Diffusion-Weighted Imaging as a Modified Abbreviated Protocol for Breast Cancer Detection

RECRUITINGSponsored by Ain Shams University
Actively Recruiting
SponsorAin Shams University
Started2025-05-10
Est. completion2026-11-15
Eligibility
Age30 Years – 50 Years
SexFEMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06970288

Summary

The aim of this study is to evaluate the added value of non-contrast abbreviated MRI protocol featuring ultra-high B value Diffusion Weighted Imaging to detect, characterize suspicious breast lesions and avoid using contrast.

Eligibility

Age: 30 Years – 50 YearsSex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

* • Women with suspicious breast mass (BIRADS 4a)

  * High risk women (Positive family history)
  * Women with suspicious axillary lymph nodes by Ultrasound
  * Women with dense breasts coming for MRI imaging.

Exclusion Criteria:

* • Contraindications to MRI

  * Pacemaker, cochlear implant, claustrophobia, ocular implants
  * Contraindications to contrast administration:
  * Elevated kidney functions
  * Women who haven't undergone reliable Mammogram \& Ultrasound
  * Women with prior treatment or intervention (e.g. biopsy)
  * Patients' refusal.

Conditions3

Breast CancerBreast CarcinomaCancer

Browse More Trials

Cancer trialsBreast Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.